<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="cytoa24702" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Cytometry A</journal-id><journal-id journal-id-type="iso-abbrev">Cytometry A</journal-id><journal-id journal-id-type="pmc-domain-id">379</journal-id><journal-id journal-id-type="pmc-domain">blackwellopen</journal-id><journal-id journal-id-type="publisher-id">CYTO</journal-id><journal-title-group><journal-title>Cytometry</journal-title></journal-title-group><issn pub-type="ppub">1552-4922</issn><issn pub-type="epub">1552-4930</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Wiley Open Access Collection</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10953369</article-id><article-id pub-id-type="pmcid-ver">PMC10953369.1</article-id><article-id pub-id-type="pmcaid">10953369</article-id><article-id pub-id-type="pmcaiid">10953369</article-id><article-id pub-id-type="pmid">36331092</article-id><article-id pub-id-type="doi">10.1002/cyto.a.24702</article-id><article-id pub-id-type="publisher-id">CYTOA24702</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="overline"><subject>Omip</subject></subj-group><subj-group subj-group-type="heading"><subject>Omip</subject></subj-group></article-categories><title-group><article-title>OMIP&#8208;086: Full spectrum flow cytometry for <styled-content style="fixed-case" toggle="no">high&#8208;dimensional</styled-content> immunophenotyping of mouse innate lymphoid cells</article-title><alt-title alt-title-type="left-running-head">Mincham and Snelgrove</alt-title></title-group><contrib-group><contrib id="cytoa24702-cr-0001" contrib-type="author" corresp="yes"><name name-style="western"><surname>Mincham</surname><given-names initials="KT">Kyle T.</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-4419-7258</contrib-id><xref rid="cytoa24702-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><address><email>k.mincham@imperial.ac.uk</email></address></contrib><contrib id="cytoa24702-cr-0002" contrib-type="author"><name name-style="western"><surname>Snelgrove</surname><given-names initials="RJ">Robert J.</given-names></name><xref rid="cytoa24702-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="cytoa24702-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">National Heart and Lung Institute</named-content>
<institution>Imperial College London</institution>
<city>London</city>
<country country="GB">UK</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
Kyle T. Mincham, National Heart and Lung Institute, Sir Alexander Fleming Building, Imperial College London, South Kensington, London SW7 2AZ, UK.<break/>
Email: <email>k.mincham@imperial.ac.uk</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>04</day><month>11</month><year>2022</year></pub-date><pub-date pub-type="ppub"><month>2</month><year>2023</year></pub-date><volume>103</volume><issue seq="70">2</issue><issue-id pub-id-type="pmc-issue-id">458263</issue-id><issue-id pub-id-type="doi">10.1002/cyto.v103.2</issue-id><issue-title content-type="special-issue-title">Cytometry and Analytical Methods in Covid&#8208;SARS&#8208;2 Diagnostics and Potential Treatment</issue-title><fpage>110</fpage><lpage>116</lpage><history><date date-type="rev-recd"><day>17</day><month>10</month><year>2022</year></date><date date-type="received"><day>17</day><month>1</month><year>2022</year></date><date date-type="accepted"><day>24</day><month>10</month><year>2022</year></date></history><pub-history><event event-type="pmc-release"><date><day>20</day><month>03</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>21</day><month>03</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-03-21 11:25:13.757"><day>21</day><month>03</month><year>2024</year></date></event></pub-history><permissions><copyright-statement content-type="article-copyright">&#169; 2022 The Authors. <italic toggle="yes">Cytometry Part A</italic> published by Wiley Periodicals LLC on behalf of International Society for Advancement of Cytometry.</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="CYTO-103-110.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="file:CYTO-103-110.pdf"/><abstract><title>Abstract</title><p>This 25&#8208;parameter, 22&#8208;color full spectrum flow cytometry panel was designed and optimized for the comprehensive enumeration and functional characterization of innate lymphoid cell (ILC) subsets in mouse tissues. The panel presented here allows the discrimination of ILC progenitors (ILCP), ILC1, ILC2, NCR<sup>+</sup> ILC3, NCR<sup>&#8722;</sup> ILC3, CCR6<sup>+</sup> lymphoid tissue&#8208;inducer (LTi)&#8208;like ILC3 and mature natural killer (NK) cell populations. Further characterization of ILC and NK cell functional profiles in response to stimulation is provided by the inclusion of subset&#8208;specific cytokine markers, and proliferation markers. Development and optimization of this panel was performed on freshly isolated cells from adult BALB/c lungs and small intestine lamina propria, and ex vivo stimulation with phorbol 12&#8208;myrisate 13&#8208;acetate, ionomycin, and pro&#8208;ILC activating cytokines.</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="cytoa24702-kwd-0001">full spectrum flow cytometry</kwd><kwd id="cytoa24702-kwd-0002">high&#8208;dimensional flow cytometry</kwd><kwd id="cytoa24702-kwd-0003">innate lymphoid cells</kwd><kwd id="cytoa24702-kwd-0004">lung</kwd><kwd id="cytoa24702-kwd-0005">small intestine lamina propria</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source>Imperial College Research Fellowship</funding-source></award-group><award-group id="funding-0002"><funding-source><institution-wrap><institution>Rosetrees Trust/The Stoneygate Trust
</institution><institution-id institution-id-type="doi">10.13039/501100000833</institution-id></institution-wrap></funding-source><award-id>PGS21/10072</award-id></award-group><award-group id="funding-0003"><funding-source><institution-wrap><institution>Wellcome Trust
</institution><institution-id institution-id-type="doi">10.13039/100010269</institution-id></institution-wrap></funding-source><award-id>209458/Z/17/Z</award-id></award-group></funding-group><counts><fig-count count="1"/><table-count count="2"/><page-count count="7"/><word-count count="5308"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-license-ref</meta-name><meta-value>CC BY</meta-value></custom-meta><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>February 2023</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.3.9 mode:remove_FC converted:20.03.2024</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="cytoa24702-cit-9001"><string-name name-style="western"><surname>Mincham</surname><given-names>KT</given-names></string-name>, <string-name name-style="western"><surname>Snelgrove</surname><given-names>RJ</given-names></string-name>. <article-title>OMIP&#8208;086: Full spectrum flow cytometry for <styled-content style="fixed-case" toggle="no">high&#8208;dimensional</styled-content> immunophenotyping of mouse innate lymphoid cells</article-title>. <source>Cytometry</source>. <year>2023</year>;<volume>103</volume>(<issue>2</issue>):<fpage>110</fpage>&#8211;<lpage>116</lpage>. <pub-id pub-id-type="doi">10.1002/cyto.a.24702</pub-id><pub-id pub-id-type="pmid">36331092</pub-id><pub-id pub-id-type="pmcid">PMC10953369</pub-id></mixed-citation>
</p><fn-group id="cytoa24702-ntgp-0001"><fn id="cytoa24702-note-0001"><p>
<italic toggle="yes">Similarities to other OMIPS</italic>: There are no published OMIPs to date characterizing ILC subsets in multiple mouse tissues.</p></fn><fn id="cytoa24702-note-1002"><p>
<bold>Funding information</bold> Imperial College Research Fellowship; Rosetrees Trust/The Stoneygate Trust, Grant/Award Number: PGS21/10072; Wellcome Trust, Grant/Award Number: 209458/Z/17/Z</p></fn></fn-group></notes></front><body id="cytoa24702-body-0001"><sec id="cytoa24702-sec-0001"><label>1</label><title>PURPOSE AND APPROPRIATE SAMPLE TYPES</title><p>This 25&#8208;parameter, 22&#8208;color full spectrum flow cytometry panel was designed and optimized for the comprehensive enumeration and functional characterization of innate lymphoid cell (ILC) subsets in mouse tissues (Table&#160;<xref rid="cytoa24702-tbl-0001" ref-type="table">1</xref>). The panel presented here allows the discrimination of ILC progenitors (ILCP), ILC1, ILC2, NCR<sup>+</sup> ILC3, NCR<sup>&#8722;</sup> ILC3, CCR6<sup>+</sup> lymphoid tissue&#8208;inducer (LTi)&#8208;like ILC3 and mature natural killer (NK) cell populations. Further characterization of ILC and NK cell functional profiles in response to stimulation is provided by the inclusion of subset&#8208;specific cytokine markers, and proliferation markers. Development and optimization of this panel was performed on freshly isolated cells from adult BALB/c lungs and small intestine lamina propria, and ex vivo stimulation with phorbol 12&#8208;myrisate 13&#8208;acetate, ionomycin, and pro&#8208;ILC activating cytokines.</p><table-wrap position="float" id="cytoa24702-tbl-0001" content-type="TABLE" orientation="portrait"><label>TABLE 1</label><caption><p>Summary table</p></caption><table frame="hsides" rules="cols"><col align="left" span="1"/><col align="left" span="1"/><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Purpose</td><td align="left" valign="top" rowspan="1" colspan="1">Deep immunophenotyping and functional assessment of ILC subsets</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Species</td><td align="left" valign="top" rowspan="1" colspan="1">Mouse</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cell types</td><td align="left" valign="top" rowspan="1" colspan="1">Innate lymphoid cells</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cross&#8208;reference</td><td align="left" valign="top" rowspan="1" colspan="1">N/A</td></tr></tbody></table><table-wrap-foot id="cytoa24702-ntgp-0002"><fn id="cytoa24702-note-0002"><p>Abbreviation: ILC, innate lymphoid cell.</p></fn></table-wrap-foot></table-wrap></sec><sec sec-type="background" id="cytoa24702-sec-0002"><label>2</label><title>BACKGROUND</title><p>ILCs are a unique subset of innate effector cells enriched at mucosal surfaces, with diverse roles in host defense, tissue remodeling and repair, inflammation, and metabolic homeostasis [<xref rid="cytoa24702-bib-0001" ref-type="bibr">1</xref>]. Despite lacking rearranged antigen receptors, ILCs display remarkable homology with conventional T helper (Th) type 1 (Th1), Th2, and Th17 cells in regards to phenotype and function, and thus are similarly classified into ILC1, ILC2, and ILC3 subsets [<xref rid="cytoa24702-bib-0002" ref-type="bibr">2</xref>]. Moreover, bona fide ILC subsets have now been expanded to include both cytotoxic NK and lymphoid tissue&#8208;inducer (LTi) cells, which are phenotypically and functionally similar to ILC1 and ILC3 respectively, yet exhibit distinct developmental trajectories [<xref rid="cytoa24702-bib-0003" ref-type="bibr">3</xref>]. However, it is increasingly recognized that ILC subsets are not fixed, and that these cells can exhibit significant plasticity depending on the local inflammatory milieu [<xref rid="cytoa24702-bib-0004" ref-type="bibr">4</xref>, <xref rid="cytoa24702-bib-0005" ref-type="bibr">5</xref>, <xref rid="cytoa24702-bib-0006" ref-type="bibr">6</xref>, <xref rid="cytoa24702-bib-0007" ref-type="bibr">7</xref>, <xref rid="cytoa24702-bib-0008" ref-type="bibr">8</xref>]. As such, ILCs demonstrate intra&#8208;subset phenotypic heterogeneity depending on their specific microenvironment [<xref rid="cytoa24702-bib-0009" ref-type="bibr">9</xref>, <xref rid="cytoa24702-bib-0010" ref-type="bibr">10</xref>], and deep immunophenotyping therefore requires a comprehensive array of phenotypic and functional markers to accurately capture this biological variation.</p><p>Although crucial in multiple biological settings, ILCs constitute a relatively minor population within both mouse and human lymphoid and non&#8208;lymphoid tissues and blood, comprising 1%&#8211;5% of CD45<sup>+</sup> leukocytes [<xref rid="cytoa24702-bib-0005" ref-type="bibr">5</xref>, <xref rid="cytoa24702-bib-0011" ref-type="bibr">11</xref>, <xref rid="cytoa24702-bib-0012" ref-type="bibr">12</xref>, <xref rid="cytoa24702-bib-0013" ref-type="bibr">13</xref>, <xref rid="cytoa24702-bib-0014" ref-type="bibr">14</xref>, <xref rid="cytoa24702-bib-0015" ref-type="bibr">15</xref>]. Due to this inherent scarcity, acquiring as much information as possible on a single&#8208;cell level is of upmost importance for accurate ILC discrimination. High resolution ILC characterization is further convoluted in tissues such as the lung and small intestine, where the intrinsically autofluorescent nature of the samples results in a heightened background noise&#8208;to&#8208;signal ratio. With this in mind, cellular characterization via full spectrum flow cytometry provides a technological advancement given its high parameter capabilities [<xref rid="cytoa24702-bib-0016" ref-type="bibr">16</xref>] combined with the capacity to extract cellular autofluorescence profiles, thus improving discrimination of rare populations compared to conventional flow cytometry [<xref rid="cytoa24702-bib-0017" ref-type="bibr">17</xref>]. As such, the full spectrum panel described herein enables the detailed enumeration and functional assessment of all ILC subsets identified within mouse tissues, with a specific focus on the characterization of lung and small intestine lamina propria (siLP) populations given the divergent repertoire of resident ILC subsets localized to these tissue compartments.</p><p>ILCs arise from common lymphoid progenitors within the bone marrow (BM), which through a series of intermediate commitment stages give rise to ILC progenitors (ILCP). While initially believed to be restricted within the BM, ILCPs are now recognized to exist within circulation and as tissue&#8208;resident populations at distal sites in both neonates and adults, including the lungs, skin, and secondary lymphoid tissues [<xref rid="cytoa24702-bib-0018" ref-type="bibr">18</xref>, <xref rid="cytoa24702-bib-0019" ref-type="bibr">19</xref>, <xref rid="cytoa24702-bib-0020" ref-type="bibr">20</xref>, <xref rid="cytoa24702-bib-0021" ref-type="bibr">21</xref>]. During early development, expression of the transcription factor promyelocytic leukemia zinc finger (PLZF; encoded by <italic toggle="yes">Zbtb16</italic>) dictates the bifurcation of innate lymphoid progenitors, whereby PLZF<sup>+</sup> ILCPs are restricted to the generation of ILC1, ILC2, and ILC3, but not LTi or NK cells [<xref rid="cytoa24702-bib-0022" ref-type="bibr">22</xref>, <xref rid="cytoa24702-bib-0023" ref-type="bibr">23</xref>]. In addition to PLZF, ILCPs display high&#8208;level expression of <italic toggle="yes">Il18r1</italic>, and thus a requirement for IL&#8208;18 signaling through IL&#8208;18R&#945; for proliferation and differentiation [<xref rid="cytoa24702-bib-0019" ref-type="bibr">19</xref>]. Importantly, both ILCPs and mature ILC subset are dependent on canonical IL&#8208;7 signaling for development and function, with expression of the receptor (IL&#8208;7R&#945;) and consumption of IL&#8208;7 dramatically greater in ILCs than their T cell counterparts [<xref rid="cytoa24702-bib-0024" ref-type="bibr">24</xref>]. Continual differentiation of IL&#8208;7R&#945;<sup>+</sup>PLZF<sup>+</sup>IL&#8208;18R&#945;<sup>+</sup> ILCP into distinct ILC subsets is under the control of a series of lineage&#8208;defining master transcription factors, with all terminal subsets lacking expression of extracellular markers routinely used to identify both lymphoid and myeloid cells, subsequently defining ILCs as lineage negative (Lin<sup>&#8722;</sup>) cells (refer to Table&#160;<xref rid="cytoa24702-tbl-0002" ref-type="table">2</xref> for all appropriate lineage markers).</p><table-wrap position="float" id="cytoa24702-tbl-0002" content-type="TABLE" orientation="portrait"><label>TABLE 2</label><caption><p>Reagents used for OMIP</p></caption><table frame="hsides" rules="cols"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Specificity</th><th align="left" valign="bottom" rowspan="1" colspan="1">Fluorochrome</th><th align="left" valign="bottom" rowspan="1" colspan="1">Clone</th><th align="left" valign="bottom" rowspan="1" colspan="1">Purpose</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">CD45</td><td align="left" valign="top" rowspan="1" colspan="1">BUV395</td><td align="left" valign="top" rowspan="1" colspan="1">30&#8208;F11</td><td align="left" valign="top" rowspan="1" colspan="1">Pan leukocytes</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">IL&#8208;7R&#945;</td><td align="left" valign="top" rowspan="1" colspan="1">PE&#8208;Cy5</td><td align="left" valign="top" rowspan="1" colspan="1">SB/199</td><td align="left" valign="top" rowspan="1" colspan="1">Pan ILC</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PLZF</td><td align="left" valign="top" rowspan="1" colspan="1">PE</td><td align="left" valign="top" rowspan="1" colspan="1">MAGS21F7</td><td align="left" valign="top" rowspan="1" colspan="1">ILCP</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">IL&#8208;18R&#945;</td><td align="left" valign="top" rowspan="1" colspan="1">PerCP&#8208;eFluor 710</td><td align="left" valign="top" rowspan="1" colspan="1">P3TUNYA</td><td align="left" valign="top" rowspan="1" colspan="1">ILCP and ILC1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">T&#8208;bet</td><td align="left" valign="top" rowspan="1" colspan="1">BV421</td><td align="left" valign="top" rowspan="1" colspan="1">4B10</td><td align="left" valign="top" rowspan="1" colspan="1">ILC1 and ILC3 subsets</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NKp46</td><td align="left" valign="top" rowspan="1" colspan="1">PE/Dazzle 594</td><td align="left" valign="top" rowspan="1" colspan="1">29A1.4</td><td align="left" valign="top" rowspan="1" colspan="1">ILC1, ILC3 subsets and NK cells</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD49a</td><td align="left" valign="top" rowspan="1" colspan="1">BUV496</td><td align="left" valign="top" rowspan="1" colspan="1">Ha31/8</td><td align="left" valign="top" rowspan="1" colspan="1">ILC1 subsets and trNK cells</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">TRAIL</td><td align="left" valign="top" rowspan="1" colspan="1">PE&#8208;Cy7</td><td align="left" valign="top" rowspan="1" colspan="1">N2B2</td><td align="left" valign="top" rowspan="1" colspan="1">ILC1 subsets</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">IFN&#8208;&#947;</td><td align="left" valign="top" rowspan="1" colspan="1">BUV737</td><td align="left" valign="top" rowspan="1" colspan="1">XMG1.2</td><td align="left" valign="top" rowspan="1" colspan="1">ILC1 and NK cells</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">GATA&#8208;3</td><td align="left" valign="top" rowspan="1" colspan="1">BB700</td><td align="left" valign="top" rowspan="1" colspan="1">L50&#8208;823</td><td align="left" valign="top" rowspan="1" colspan="1">ILC2</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">KLRG1</td><td align="left" valign="top" rowspan="1" colspan="1">BV480</td><td align="left" valign="top" rowspan="1" colspan="1">2F1</td><td align="left" valign="top" rowspan="1" colspan="1">ILC2</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ST2</td><td align="left" valign="top" rowspan="1" colspan="1">R718</td><td align="left" valign="top" rowspan="1" colspan="1">U29&#8208;93</td><td align="left" valign="top" rowspan="1" colspan="1">ILC2</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">IL&#8208;5</td><td align="left" valign="top" rowspan="1" colspan="1">APC</td><td align="left" valign="top" rowspan="1" colspan="1">TRFK5</td><td align="left" valign="top" rowspan="1" colspan="1">ILC2</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">IL&#8208;13</td><td align="left" valign="top" rowspan="1" colspan="1">eFluor 450</td><td align="left" valign="top" rowspan="1" colspan="1">eBio13A</td><td align="left" valign="top" rowspan="1" colspan="1">ILC2</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ROR&#947;t</td><td align="left" valign="top" rowspan="1" colspan="1">BV786</td><td align="left" valign="top" rowspan="1" colspan="1">Q31&#8208;378</td><td align="left" valign="top" rowspan="1" colspan="1">ILC3</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CCR6</td><td align="left" valign="top" rowspan="1" colspan="1">BV711</td><td align="left" valign="top" rowspan="1" colspan="1">140706</td><td align="left" valign="top" rowspan="1" colspan="1">ILC3 subsets</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">IL&#8208;17A</td><td align="left" valign="top" rowspan="1" colspan="1">BV650</td><td align="left" valign="top" rowspan="1" colspan="1">TC11&#8208;18H10.1</td><td align="left" valign="top" rowspan="1" colspan="1">ILC3</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">IL&#8208;22</td><td align="left" valign="top" rowspan="1" colspan="1">Alexa Fluor 647</td><td align="left" valign="top" rowspan="1" colspan="1">Poly5164</td><td align="left" valign="top" rowspan="1" colspan="1">ILC3</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD49b</td><td align="left" valign="top" rowspan="1" colspan="1">eFluor 506</td><td align="left" valign="top" rowspan="1" colspan="1">DX5</td><td align="left" valign="top" rowspan="1" colspan="1">NK cells</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Ki&#8208;67</td><td align="left" valign="top" rowspan="1" colspan="1">Alexa Fluor 532</td><td align="left" valign="top" rowspan="1" colspan="1">SolA15</td><td align="left" valign="top" rowspan="1" colspan="1">Proliferating cells</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">B220</td><td align="left" valign="top" rowspan="1" colspan="1">FITC</td><td align="left" valign="top" rowspan="1" colspan="1">RA3&#8208;6B2</td><td align="left" valign="top" rowspan="1" colspan="1">B cell subsets (Lin dump)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD3</td><td align="left" valign="top" rowspan="1" colspan="1">FITC</td><td align="left" valign="top" rowspan="1" colspan="1">145&#8208;2C11</td><td align="left" valign="top" rowspan="1" colspan="1">T cell subsets (Lin dump)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD4</td><td align="left" valign="top" rowspan="1" colspan="1">FITC</td><td align="left" valign="top" rowspan="1" colspan="1">GK1.5</td><td align="left" valign="top" rowspan="1" colspan="1">T cell subsets (Lin dump)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD5</td><td align="left" valign="top" rowspan="1" colspan="1">FITC</td><td align="left" valign="top" rowspan="1" colspan="1">53&#8208;7.3</td><td align="left" valign="top" rowspan="1" colspan="1">T cell and B cell subsets (Lin dump)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD11b</td><td align="left" valign="top" rowspan="1" colspan="1">FITC</td><td align="left" valign="top" rowspan="1" colspan="1">M1/70</td><td align="left" valign="top" rowspan="1" colspan="1">Myeloid/NK/Granulocytes (Lin dump)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD11c</td><td align="left" valign="top" rowspan="1" colspan="1">FITC</td><td align="left" valign="top" rowspan="1" colspan="1">N418</td><td align="left" valign="top" rowspan="1" colspan="1">Myeloid cells/Granulocytes (Lin dump)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD19</td><td align="left" valign="top" rowspan="1" colspan="1">FITC</td><td align="left" valign="top" rowspan="1" colspan="1">1D3/CD19</td><td align="left" valign="top" rowspan="1" colspan="1">B cell subsets (Lin dump)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">F4/80</td><td align="left" valign="top" rowspan="1" colspan="1">FITC</td><td align="left" valign="top" rowspan="1" colspan="1">BM8</td><td align="left" valign="top" rowspan="1" colspan="1">Macrophages (Lin dump)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Fc&#949;R1&#945;</td><td align="left" valign="top" rowspan="1" colspan="1">FITC</td><td align="left" valign="top" rowspan="1" colspan="1">MAR&#8208;1</td><td align="left" valign="top" rowspan="1" colspan="1">Mast cells and Basophils (Lin dump)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Gr&#8208;1</td><td align="left" valign="top" rowspan="1" colspan="1">FITC</td><td align="left" valign="top" rowspan="1" colspan="1">RB6&#8208;85C</td><td align="left" valign="top" rowspan="1" colspan="1">Myeloid cells/Granulocytes (Lin dump)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">TCR&#946;</td><td align="left" valign="top" rowspan="1" colspan="1">FITC</td><td align="left" valign="top" rowspan="1" colspan="1">H57&#8208;597</td><td align="left" valign="top" rowspan="1" colspan="1">&#945;&#946; T&#8208;cells (Lin dump)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">TCR&#947;&#948;</td><td align="left" valign="top" rowspan="1" colspan="1">FITC</td><td align="left" valign="top" rowspan="1" colspan="1">UC7&#8208;13D5</td><td align="left" valign="top" rowspan="1" colspan="1">&#947;&#948; T&#8208;cells (Lin dump)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Ter119</td><td align="left" valign="top" rowspan="1" colspan="1">FITC</td><td align="left" valign="top" rowspan="1" colspan="1">TER&#8208;119</td><td align="left" valign="top" rowspan="1" colspan="1">Red blood cells (Lin dump)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Dead cells</td><td align="left" valign="top" rowspan="1" colspan="1">LIVE/DEAD&#8482; Blue</td><td align="left" valign="top" rowspan="1" colspan="1">&#8208;</td><td align="left" valign="top" rowspan="1" colspan="1">Viable cells</td></tr></tbody></table></table-wrap><p>ILC1s are characterized by their constitutive expression of T&#8208;bet (encoded by <italic toggle="yes">Tbx21</italic>), which is central for their production of interferon (IFN)&#8208;&#947; and ensuing response to intracellular pathogens following IL&#8208;12 and IL&#8208;18 stimulation [<xref rid="cytoa24702-bib-0018" ref-type="bibr">18</xref>, <xref rid="cytoa24702-bib-0025" ref-type="bibr">25</xref>]. Owing to their similarities with cytotoxic NK cells, ILC1s express NKp46, however tissue&#8208;specific distinctions can be made between these two subsets via the preferential expression of CD49a and/or TRAIL by ILC1, in conjunction with the absence of CD11b and CD49b [<xref rid="cytoa24702-bib-0003" ref-type="bibr">3</xref>, <xref rid="cytoa24702-bib-0018" ref-type="bibr">18</xref>, <xref rid="cytoa24702-bib-0025" ref-type="bibr">25</xref>].</p><p>ILC2s represent the most abundant subset of ILCs in mouse lungs [<xref rid="cytoa24702-bib-0005" ref-type="bibr">5</xref>] and are dependent on the expression of GATA&#8208;3 for maintenance and survival [<xref rid="cytoa24702-bib-0026" ref-type="bibr">26</xref>, <xref rid="cytoa24702-bib-0027" ref-type="bibr">27</xref>]. Analogous to their Th2 counterparts, ILC2s play a key role in controlling helminth infection [<xref rid="cytoa24702-bib-0026" ref-type="bibr">26</xref>, <xref rid="cytoa24702-bib-0028" ref-type="bibr">28</xref>, <xref rid="cytoa24702-bib-0029" ref-type="bibr">29</xref>], while perpetuating allergen&#8208;induced allergic inflammation [<xref rid="cytoa24702-bib-0030" ref-type="bibr">30</xref>, <xref rid="cytoa24702-bib-0031" ref-type="bibr">31</xref>, <xref rid="cytoa24702-bib-0032" ref-type="bibr">32</xref>, <xref rid="cytoa24702-bib-0033" ref-type="bibr">33</xref>] via the production of IL&#8208;5 and IL&#8208;13 in response to alarmins IL&#8208;33, IL&#8208;25, and thymic stromal lymphopoietin (TSLP). Given their extensive roles in both immunity and inflammation, ILC2s are known to display dynamic expression of extracellular markers associated with pro&#8208;inflammatory functions, exemplified via variations in IL&#8208;33 receptor (ST2) and KLRG1 expression depending on the inflammatory signal initiating the primary response [<xref rid="cytoa24702-bib-0013" ref-type="bibr">13</xref>, <xref rid="cytoa24702-bib-0034" ref-type="bibr">34</xref>, <xref rid="cytoa24702-bib-0035" ref-type="bibr">35</xref>]. Moreover, the inflammation&#8208;dependent plasticity of ILC2s has been demonstrated in both mouse lungs and human peripheral blood, whereby stimulation with IL&#8208;1&#946;, IL&#8208;12, and IL&#8208;18 promotes ILC2s to adopt an ILC1&#8208;like transcriptional and functional profile associated with the expression of T&#8208;bet (<italic toggle="yes">Tbx21</italic>) and production of IFN&#8208;&#947; [<xref rid="cytoa24702-bib-0005" ref-type="bibr">5</xref>, <xref rid="cytoa24702-bib-0006" ref-type="bibr">6</xref>, <xref rid="cytoa24702-bib-0034" ref-type="bibr">34</xref>, <xref rid="cytoa24702-bib-0036" ref-type="bibr">36</xref>]. Similarly, human ILC2s, in response to IL&#8208;1&#946; and IL&#8208;23 stimulation, transdifferentiate into a subset exhibiting ILC3&#8208;like characteristics, evidenced by upregulation of the ILC3 signature transcription factor ROR&#947;t and production of IL&#8208;17 [<xref rid="cytoa24702-bib-0008" ref-type="bibr">8</xref>, <xref rid="cytoa24702-bib-0037" ref-type="bibr">37</xref>].</p><p>ILC3s are a heterogeneous subset and contribute broad roles in combating against extracellular microbes, including fungi and bacteria, via the production of IL&#8208;17A and IL&#8208;22 following IL&#8208;1&#946; and IL&#8208;23&#8208;mediated activation [<xref rid="cytoa24702-bib-0038" ref-type="bibr">38</xref>, <xref rid="cytoa24702-bib-0039" ref-type="bibr">39</xref>, <xref rid="cytoa24702-bib-0040" ref-type="bibr">40</xref>]. Representing the dominant ILC subset within the steady state siLP [<xref rid="cytoa24702-bib-0041" ref-type="bibr">41</xref>], ILC3s are strictly reliant upon ROR&#947;t (encoded by <italic toggle="yes">Rorc</italic>) expression for development and function [<xref rid="cytoa24702-bib-0039" ref-type="bibr">39</xref>, <xref rid="cytoa24702-bib-0042" ref-type="bibr">42</xref>, <xref rid="cytoa24702-bib-0043" ref-type="bibr">43</xref>]. However, mouse ILC3s can be further classified into three subtypes based on the differential expression of NKp46 and CCR6; namely NKp46<sup>+</sup>CCR6<sup>&#8722;</sup> (NCR<sup>+</sup>), NKp46<sup>&#8722;</sup>CCR6<sup>&#8722;</sup> (NCR<sup>&#8722;</sup>), and NKp46<sup>&#8722;</sup>CCR6<sup>+</sup> (CCR6<sup>+</sup> LTi&#8208;like) ILC3s [<xref rid="cytoa24702-bib-0042" ref-type="bibr">42</xref>, <xref rid="cytoa24702-bib-0044" ref-type="bibr">44</xref>, <xref rid="cytoa24702-bib-0045" ref-type="bibr">45</xref>]. Moreover, NCR<sup>+</sup> ILC3s share transcriptional expression of T&#8208;bet with ILC1s, crucial for their expression of NKp46 and endowing them with the ability to produce IFN&#8208;&#947; [<xref rid="cytoa24702-bib-0046" ref-type="bibr">46</xref>, <xref rid="cytoa24702-bib-0047" ref-type="bibr">47</xref>]. Furthermore, stimulation of mouse tissue&#8208;specific NCR<sup>+</sup> ILC3s with IL&#8208;12 promotes downregulation of ROR&#947;t and concomitant upregulation of T&#8208;bet, further promoting a phenotype associated with IFN&#8208;&#947;<sup>+</sup> ILC1s [<xref rid="cytoa24702-bib-0004" ref-type="bibr">4</xref>] and demonstrating their plasticity in response to environmental cues.</p><p>Given this microenvironmental&#8208;driven impact on ILC heterogeneity, the developmental phase of this full spectrum flow cytometry panel involved the prioritization of definitive ILCP, ILC1, ILC2, and ILC3 transcription factors, as reflected in the gating strategy (Figure&#160;<xref rid="cytoa24702-fig-0001" ref-type="fig">1</xref>). An added benefit of full spectrum flow cytometry is the ability to remove red blood cell contamination by plotting side&#8208;scatter (SSC) captured by the 405&#8201;nm violet laser against SSC&#8208;B from the 488&#8201;nm blue laser [<xref rid="cytoa24702-bib-0048" ref-type="bibr">48</xref>] (Figure&#160;<xref rid="cytoa24702-fig-0001" ref-type="fig">1A</xref>), thus ensuring purity of downstream terminal cell populations. Viable leukocytes (LIVE/DEAD Blue<sup>&#8722;</sup> CD45<sup>+</sup>; Figure&#160;<xref rid="cytoa24702-fig-0001" ref-type="fig">1A</xref>) were selected and total ILCs were defined by their expression of IL&#8208;7R&#945;<sup>+</sup> and lack of lineage markers used to routinely define T cells, B cells, myeloid cells, and red blood cells (CD3, CD4, CD5, CD11b, CD11c, CD19, B220, F4/80, Fc&#949;R1, Gr1, TCR&#946;, TCR&#947;&#948;, Ter119; Figure&#160;<xref rid="cytoa24702-fig-0001" ref-type="fig">1B</xref>). ILCPs within the lung were characterized by their ubiquitous expression of PLZF, in combination with IL&#8208;18R&#945;<sup>+</sup> (Figure&#160;<xref rid="cytoa24702-fig-0001" ref-type="fig">1C</xref>). Mature ILC subsets within the lung (Figure&#160;<xref rid="cytoa24702-fig-0001" ref-type="fig">1D</xref>) and siLP (Figure&#160;<xref rid="cytoa24702-fig-0001" ref-type="fig">1E</xref>) were stratified as T&#8208;bet<sup>+</sup>ROR&#947;t<sup>&#8722;</sup>ST2<sup>&#8722;</sup>CD49b<sup>&#8722;</sup>IL&#8208;18R&#945;<sup>+</sup>NKp46<sup>+</sup>CD49a<sup>+/&#8722;</sup>TRAIL<sup>+/&#8722;</sup> ILC1s, GATA&#8208;3<sup>+</sup>T&#8208;bet<sup>&#8722;</sup>ROR&#947;t<sup>&#8722;</sup>KLRG1<sup>+/&#8722;</sup>ST2<sup>+/&#8722;</sup> ILC2s and either ROR&#947;t<sup>+</sup>T&#8208;bet<sup>+/&#8722;</sup>NKp46<sup>+</sup>CCR6<sup>&#8722;</sup> (NCR<sup>+</sup>), ROR&#947;t<sup>+</sup>T&#8208;bet<sup>+/&#8722;</sup>NKp46<sup>&#8722;</sup>CCR6<sup>&#8722;</sup> (NCR<sup>&#8722;</sup>) or ROR&#947;t<sup>+</sup>T&#8208;bet<sup>+/&#8722;</sup>NKp46<sup>&#8722;</sup>CCR6<sup>+</sup> (CCR6<sup>+</sup> LTi&#8208;like) ILC3s. Regarding ILC2s, it is important to note that ST2 expression on ex vivo stimulated siLP ILC2s is largely absent (Figure&#160;<xref rid="cytoa24702-fig-0001" ref-type="fig">1E</xref>) [<xref rid="cytoa24702-bib-0009" ref-type="bibr">9</xref>, <xref rid="cytoa24702-bib-0049" ref-type="bibr">49</xref>]. Moreover, while lung ILCs lack CD4 expression [<xref rid="cytoa24702-bib-0050" ref-type="bibr">50</xref>], intestinal CCR6<sup>+</sup> LTi&#8208;like ILC3s can be sub&#8208;classified as CD4<sup>+</sup> and CD4<sup>&#8722;</sup> [<xref rid="cytoa24702-bib-0051" ref-type="bibr">51</xref>]. As such, the inclusion of CD4 within the lineage cocktail may influence the characterization of ILC3 subsets on a tissue&#8208;specific basis. ILC cytokine production and proliferation within the lung (Figure&#160;<xref rid="cytoa24702-fig-0001" ref-type="fig">1F</xref>) and siLP (Figure&#160;<xref rid="cytoa24702-fig-0001" ref-type="fig">1G</xref>) was assessed in response to subset&#8208;specific activation signals via ex vivo stimulation with phorbol 12&#8208;myrisate 13&#8208;acetate (PMA), Ionomycin and Brefeldin A, and either IL&#8208;12 and IL&#8208;18 (pro&#8208;ILC1), IL&#8208;33 (pro&#8208;ILC2) or IL&#8208;1&#946; and IL&#8208;23 (pro&#8208;ILC3). Stimulation with ILC subset&#8208;specific cytokines clearly demonstrates a heightened propensity for IL&#8208;13 and IL&#8208;22 production by siLP ILC2s and ILC3 subsets respectively, whereas lung ILC1s significantly upregulate IFN&#8208;&#947; compared to their siLP counterparts. Although the focus of this panel was to accurately define ILCPs and ILC1&#8208;3 subsets, inclusion of CD11b within the lineage cocktail enables the enumeration of conventional mature CD11b<sup>+</sup>NKp46<sup>+</sup>T&#8208;bet<sup>+</sup> NK cells (Figure&#160;<xref rid="cytoa24702-fig-0001" ref-type="fig">1H</xref>) [<xref rid="cytoa24702-bib-0052" ref-type="bibr">52</xref>], with additional characterization of lung tissue&#8208;resident (trNK) and circulating (cNK) populations on the basis of CD49a and CD49b expression [<xref rid="cytoa24702-bib-0053" ref-type="bibr">53</xref>] (Figure&#160;<xref rid="cytoa24702-fig-0001" ref-type="fig">1H</xref>). Markers including KLRG1 [<xref rid="cytoa24702-bib-0054" ref-type="bibr">54</xref>] and ROR&#947;t [<xref rid="cytoa24702-bib-0055" ref-type="bibr">55</xref>], and cytokines IFN&#8208;&#947;, IL&#8208;5, IL&#8208;13 [<xref rid="cytoa24702-bib-0056" ref-type="bibr">56</xref>] and IL&#8208;22 [<xref rid="cytoa24702-bib-0057" ref-type="bibr">57</xref>] are all reportedly expressed by NK cell subsets based on maturation, tissue localization and disease state, further highlighting the diversity of this OMIP.</p><fig position="float" fig-type="FIGURE" id="cytoa24702-fig-0001" orientation="portrait"><label>FIGURE 1</label><caption><p>Gating strategy to characterize innate lymphoid cell (ILC) populations and their subset&#8208;specific cytokine and proliferative profiles. After exclusion of cellular debris, doublets, red blood cell contamination and non&#8208;viable CD45<sup>+/&#8722;</sup> cells, viable CD45<sup>+</sup> leukocytes (A) were gated on IL&#8208;7R&#945; and lineage (CD3, CD4, CD5, CD11b, CD11c, CD19, B220, F4/80, Fc&#949;R1, Gr1, TCR&#946;, TCR&#947;&#948;, Ter119; Lin) negative cells to identify ILCs (B). ILCPs were then identified as IL&#8208;18R&#945;<sup>+</sup>PLZF<sup>+</sup> cells (C). Characterization of ILC1, ILC2, NCR<sup>+</sup>, NCR<sup>&#8722;</sup> and CCR6<sup>+</sup> LTi&#8208;like ILC3 subsets in the lung (D) and siLP (E). All samples in panel (A&#8211;E) were ex vivo stimulated for 5&#160;h with PMA/Ionomycin/BFA. Single cell suspensions were ex vivo stimulated for 5&#160;h with PMA/Ionomycin/BFA and either IL&#8208;12 and IL&#8208;18 (pro&#8208;ILC1), IL&#8208;33 (pro&#8208;ILC2), or IL&#8208;1&#946; and IL&#8208;23 (pro&#8208;ILC3) and ILC subsets were assessed for production of subset&#8208;specific cytokines (IFN&#8208;&#947;, IL&#8208;5, IL&#8208;13, IL&#8208;17A, and IL&#8208;22) and cellular proliferation (Ki&#8208;67) within the lung (F) and siLP (G). (H) Identification of NK cells within the lung and siLP, with downstream characterization of lung tissue&#8208;resident NK (trNK) and circulating NK (cNK) cells. Plots in panel (A&#8211;C) are representative of individual lung samples. For panels (B&#8211;H), viable leukocytes from three technical lung or siLP replicates were concatenated into single FCS files prior to gating. All fluorochrome&#8208;conjugated antibodies were titrated (Figure&#160;<xref rid="cytoa24702-supitem-0001" ref-type="supplementary-material">S1</xref>) during panel optimization and manual gating was determined using fluorescence minus one controls (Figure&#160;<xref rid="cytoa24702-supitem-0001" ref-type="supplementary-material">S2</xref>) where necessary [Color figure can be viewed at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://wileyonlinelibrary.com" ext-link-type="uri">wileyonlinelibrary.com</ext-link>]</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-1" orientation="portrait" xlink:href="CYTO-103-110-g001.jpg"/></fig><p>In summary, we present here the first full spectrum flow cytometry panel (Table&#160;<xref rid="cytoa24702-tbl-0002" ref-type="table">2</xref>) to comprehensively profile the phenotypic and functional state of ILCs in multiple mouse tissues. Moreover, by maintaining availability on the 355&#8201;nm ultraviolet laser, this panel can be expanded to incorporate additional markers of interest with little impact on the overall Complexity&#8482; Index (a value of how distinct a collection of spectral signatures are from one other when unmixed simultaneously), thereby providing a valuable resource within the rapidly expanding field of ILC biology.</p></sec><sec id="cytoa24702-sec-0006"><title>AUTHOR CONTRIBUTIONS</title><p>
<bold>Kyle T Mincham:</bold> Conceptualization (lead); data curation (lead); formal analysis (lead); investigation (lead); methodology (lead); validation (lead); visualization (lead); writing &#8211; original draft (lead); writing &#8211; review and editing (equal). <bold>Robert J Snelgrove:</bold> Conceptualization (supporting); funding acquisition (lead); project administration (lead); resources (lead); supervision (lead); writing &#8211; original draft (supporting); writing &#8211; review and editing (equal).</p></sec><sec sec-type="COI-statement" id="cytoa24702-sec-0005"><title>CONFLICT OF INTEREST</title><p>The author declare that no conflicts of interest exist.</p></sec><sec id="cytoa24702-sec-0007"><label>3</label><sec id="cytoa24702-sec-0008"><title>PEER REVIEW</title><p>The peer review history for this article is available at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://publons.com/publon/10.1002/cyto.a.24702" ext-link-type="uri">https://publons.com/publon/10.1002/cyto.a.24702</ext-link>.</p></sec></sec><sec id="cytoa24702-sec-0004"><title>ETHICS STATEMENT</title><p>All mouse experiments were performed in accordance with the recommendations in the Guide for the Use of Laboratory Animals of Imperial College London, with the ARRIVE (Animal Research: Reporting of In Vivo Experiments) guidelines. All animal procedures and care conformed strictly to the UK Home Office Guidelines under the Animals (Scientific Procedures) Act 1986, and the protocols were approved by the Home Office of Great Britain.</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="cytoa24702-supitem-0001" position="float" content-type="local-data" orientation="portrait"><caption><p>
<bold>APPENDIX S1.</bold> Supporting Information.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="CYTO-103-110-s001.docx" position="float" orientation="portrait"/></supplementary-material><supplementary-material id="cytoa24702-supitem-0002" position="float" content-type="local-data" orientation="portrait"><caption><p>
<bold>MIFlowCyt</bold> Mi Flow checklist.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="CYTO-103-110-s002.docx" position="float" orientation="portrait"/></supplementary-material></sec></body><back><ack id="cytoa24702-sec-0003"><title>ACKNOWLEDGMENTS</title><p>The authors would like to thank Dr James Harker and the Imperial College London Flow Cytometry Facility South Kensington for their valuable advice on Cytek&#174; Aurora operation during the initial design of this panel. In addition, the authors would like to thank Christopher McRandle and Dr Adam Davison from Cytek&#174; Biosciences for their advice on data quality control using SpectroFlo&#174; software. The authors acknowledge financial support from Imperial College London through an Imperial College Research Fellowship grant awarded to Kyle T. Mincham. Robert J. Snelgrove is a Wellcome Trust Senior Research Fellow in Basic Biomedical Sciences (209458/Z/17/Z). Parts of this work were also funded through a Rosetrees Trust/The Stoneygate Trust Project Grant (PGS21/10072).</p></ack><ref-list id="cytoa24702-bibl-0001" content-type="cited-references"><title>REFERENCES</title><ref id="cytoa24702-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="cytoa24702-cit-0001"><string-name name-style="western"><surname>Klose</surname><given-names>CSN</given-names></string-name>, <string-name name-style="western"><surname>Artis</surname><given-names>D</given-names></string-name>. <article-title>Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis</article-title>. <source>Nat Immunol</source>. <year>2016</year>;<volume>17</volume>(<issue>7</issue>):<fpage>765</fpage>&#8211;<lpage>74</lpage>.<pub-id pub-id-type="pmid">27328006</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ni.3489</pub-id></mixed-citation></ref><ref id="cytoa24702-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="cytoa24702-cit-0002"><string-name name-style="western"><surname>Spits</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Artis</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Colonna</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Diefenbach</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>di Santo</surname><given-names>JP</given-names></string-name>, <string-name name-style="western"><surname>Eberl</surname><given-names>G</given-names></string-name>, et al. <article-title>Innate lymphoid cells&#8212;a proposal for uniform nomenclature</article-title>. <source>Nat Rev Immunol</source>. <year>2013</year>;<volume>13</volume>(<issue>2</issue>):<fpage>145</fpage>&#8211;<lpage>9</lpage>.<pub-id pub-id-type="pmid">23348417</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nri3365</pub-id></mixed-citation></ref><ref id="cytoa24702-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="cytoa24702-cit-0003"><string-name name-style="western"><surname>Vivier</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Artis</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Colonna</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Diefenbach</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>di Santo</surname><given-names>JP</given-names></string-name>, <string-name name-style="western"><surname>Eberl</surname><given-names>G</given-names></string-name>, et al. <article-title>Innate lymphoid cells: 10&#8201;years on</article-title>. <source>Cell</source>. <year>2018</year>;<volume>174</volume>(<issue>5</issue>):<fpage>1054</fpage>&#8211;<lpage>66</lpage>.<pub-id pub-id-type="pmid">30142344</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2018.07.017</pub-id></mixed-citation></ref><ref id="cytoa24702-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="cytoa24702-cit-0004"><string-name name-style="western"><surname>Vonarbourg</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Mortha</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Bui</surname><given-names>VL</given-names></string-name>, <string-name name-style="western"><surname>Hernandez</surname><given-names>PP</given-names></string-name>, <string-name name-style="western"><surname>Kiss</surname><given-names>EA</given-names></string-name>, <string-name name-style="western"><surname>Hoyler</surname><given-names>T</given-names></string-name>, et al. <article-title>Regulated expression of nuclear receptor ROR&#947;t confers distinct functional fates to NK cell receptor&#8208;expressing ROR&#947;t+ innate lymphocytes</article-title>. <source>Immunity</source>. <year>2010</year>;<volume>33</volume>(<issue>5</issue>):<fpage>736</fpage>&#8211;<lpage>51</lpage>.<pub-id pub-id-type="pmid">21093318</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.immuni.2010.10.017</pub-id><pub-id pub-id-type="pmcid">PMC3042726</pub-id></mixed-citation></ref><ref id="cytoa24702-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="cytoa24702-cit-0005"><string-name name-style="western"><surname>Silver</surname><given-names>JS</given-names></string-name>, <string-name name-style="western"><surname>Kearley</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Copenhaver</surname><given-names>AM</given-names></string-name>, <string-name name-style="western"><surname>Sanden</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Mori</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Yu</surname><given-names>L</given-names></string-name>, et al. <article-title>Inflammatory triggers associated with exacerbations of COPD orchestrate plasticity of group 2 innate lymphoid cells in the lungs</article-title>. <source>Nat Immunol</source>. <year>2016</year>;<volume>17</volume>(<issue>6</issue>):<fpage>626</fpage>&#8211;<lpage>35</lpage>.<pub-id pub-id-type="pmid">27111143</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ni.3443</pub-id><pub-id pub-id-type="pmcid">PMC5345745</pub-id></mixed-citation></ref><ref id="cytoa24702-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="cytoa24702-cit-0006"><string-name name-style="western"><surname>Bal</surname><given-names>SM</given-names></string-name>, <string-name name-style="western"><surname>Bernink</surname><given-names>JH</given-names></string-name>, <string-name name-style="western"><surname>Nagasawa</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Groot</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Shikhagaie</surname><given-names>MM</given-names></string-name>, <string-name name-style="western"><surname>Golebski</surname><given-names>K</given-names></string-name>, et al. <article-title>IL&#8208;1&#946;, IL&#8208;4 and IL&#8208;12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs</article-title>. <source>Nat Immunol</source>. <year>2016</year>;<volume>17</volume>(<issue>6</issue>):<fpage>636</fpage>&#8211;<lpage>45</lpage>.<pub-id pub-id-type="pmid">27111145</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ni.3444</pub-id></mixed-citation></ref><ref id="cytoa24702-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="cytoa24702-cit-0007"><string-name name-style="western"><surname>Bernink</surname><given-names>JH</given-names></string-name>, <string-name name-style="western"><surname>Krabbendam</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Germar</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>de Jong</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Gronke</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Kofoed&#8208;Nielsen</surname><given-names>M</given-names></string-name>, et al. <article-title>Interleukin&#8208;12 and &#8208;23 control plasticity of CD127+ group 1 and group 3 innate lymphoid cells in the intestinal lamina propria</article-title>. <source>Immunity</source>. <year>2015</year>;<volume>43</volume>(<issue>1</issue>):<fpage>146</fpage>&#8211;<lpage>60</lpage>.<pub-id pub-id-type="pmid">26187413</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.immuni.2015.06.019</pub-id></mixed-citation></ref><ref id="cytoa24702-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="cytoa24702-cit-0008"><string-name name-style="western"><surname>Bernink</surname><given-names>JH</given-names></string-name>, <string-name name-style="western"><surname>Ohne</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Teunissen</surname><given-names>MBM</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Wu</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Krabbendam</surname><given-names>L</given-names></string-name>, et al. <article-title>c&#8208;Kit&#8208;positive ILC2s exhibit an ILC3&#8208;like signature that may contribute to IL&#8208;17&#8208;mediated pathologies</article-title>. <source>Nat Immunol</source>. <year>2019</year>;<volume>20</volume>(<issue>8</issue>):<fpage>992</fpage>&#8211;<lpage>1003</lpage>.<pub-id pub-id-type="pmid">31263279</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41590-019-0423-0</pub-id></mixed-citation></ref><ref id="cytoa24702-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="cytoa24702-cit-0009"><string-name name-style="western"><surname>Meininger</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Carrasco</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Rao</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Soini</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Kokkinou</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Mj&#246;sberg</surname><given-names>J</given-names></string-name>. <article-title>Tissue&#8208;specific features of innate lymphoid cells</article-title>. <source>Trends Immunol</source>. <year>2020</year>;<volume>41</volume>(<issue>10</issue>):<fpage>902</fpage>&#8211;<lpage>17</lpage>.<pub-id pub-id-type="pmid">32917510</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.it.2020.08.009</pub-id></mixed-citation></ref><ref id="cytoa24702-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="cytoa24702-cit-0010"><string-name name-style="western"><surname>Loering</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Cameron</surname><given-names>GJ</given-names></string-name>, <string-name name-style="western"><surname>Bhatt</surname><given-names>NP</given-names></string-name>, <string-name name-style="western"><surname>Belz</surname><given-names>GT</given-names></string-name>, <string-name name-style="western"><surname>Foster</surname><given-names>PS</given-names></string-name>, <string-name name-style="western"><surname>Hansbro</surname><given-names>PM</given-names></string-name>, et al. <article-title>Differences in pulmonary group 2 innate lymphoid cells are dependent on mouse age, sex and strain</article-title>. <source>Immunol Cell Biol</source>. <year>2021</year>;<volume>99</volume>(<issue>5</issue>):<fpage>542</fpage>&#8211;<lpage>51</lpage>.<pub-id pub-id-type="pmid">33295058</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/imcb.12430</pub-id></mixed-citation></ref><ref id="cytoa24702-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="cytoa24702-cit-0011"><string-name name-style="western"><surname>Mackley</surname><given-names>EC</given-names></string-name>, <string-name name-style="western"><surname>Houston</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Marriott</surname><given-names>CL</given-names></string-name>, <string-name name-style="western"><surname>Halford</surname><given-names>EE</given-names></string-name>, <string-name name-style="western"><surname>Lucas</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Cerovic</surname><given-names>V</given-names></string-name>, et al. <article-title>CCR7&#8208;dependent trafficking of ROR&#947;+ ILCs creates a unique microenvironment within mucosal draining lymph nodes</article-title>. <source>Nat Commun</source>. <year>2015</year>;<volume>6</volume>(<issue>1</issue>):<fpage>5862</fpage>.<pub-id pub-id-type="pmid">25575242</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ncomms6862</pub-id><pub-id pub-id-type="pmcid">PMC4354100</pub-id></mixed-citation></ref><ref id="cytoa24702-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="cytoa24702-cit-0012"><string-name name-style="western"><surname>Gronke</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Kofoed&#8208;Nielsen</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Diefenbach</surname><given-names>A</given-names></string-name>. <article-title>Isolation and flow cytometry analysis of innate lymphoid cells from the intestinal lamina propria</article-title>. <source>Methods Mol Biol</source>. <year>2017</year>;<volume>1559</volume>:<fpage>255</fpage>.<pub-id pub-id-type="pmid">28063049</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/978-1-4939-6786-5_17</pub-id></mixed-citation></ref><ref id="cytoa24702-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="cytoa24702-cit-0013"><string-name name-style="western"><surname>Entwistle</surname><given-names>LJ</given-names></string-name>, <string-name name-style="western"><surname>Gregory</surname><given-names>LG</given-names></string-name>, <string-name name-style="western"><surname>Oliver</surname><given-names>RA</given-names></string-name>, <string-name name-style="western"><surname>Branchett</surname><given-names>WJ</given-names></string-name>, <string-name name-style="western"><surname>Puttur</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Lloyd</surname><given-names>CM</given-names></string-name>. <article-title>Pulmonary group 2 innate lymphoid cell phenotype is context specific: determining the effect of strain, location, and stimuli</article-title>. <source>Front Immunol</source>. <year>2020</year>;<volume>10</volume>:<fpage>3114</fpage>.<pub-id pub-id-type="pmid">32038635</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2019.03114</pub-id><pub-id pub-id-type="pmcid">PMC6987460</pub-id></mixed-citation></ref><ref id="cytoa24702-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="cytoa24702-cit-0014"><string-name name-style="western"><surname>V&#233;ly</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Barlogis</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Vallentin</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Neven</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Piperoglou</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Ebbo</surname><given-names>M</given-names></string-name>, et al. <article-title>Evidence of innate lymphoid cell redundancy in humans</article-title>. <source>Nat Immunol</source>. <year>2016</year>;<volume>17</volume>(<issue>11</issue>):<fpage>1291</fpage>&#8211;<lpage>9</lpage>.<pub-id pub-id-type="pmid">27618553</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ni.3553</pub-id><pub-id pub-id-type="pmcid">PMC5074366</pub-id></mixed-citation></ref><ref id="cytoa24702-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="cytoa24702-cit-0015"><string-name name-style="western"><surname>Bennstein</surname><given-names>SB</given-names></string-name>, <string-name name-style="western"><surname>Weinhold</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Manser</surname><given-names>AR</given-names></string-name>, <string-name name-style="western"><surname>Scherenschlich</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Noll</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Raba</surname><given-names>K</given-names></string-name>, et al. <article-title>Umbilical cord blood&#8208;derived ILC1&#8208;like cells constitute a novel precursor for mature KIR+NKG2A&#8208;NK cells</article-title>. <source>Elife</source>. <year>2020</year>;<volume>9</volume>:<elocation-id>e55232</elocation-id>.<pub-id pub-id-type="pmid">32657756</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7554/eLife.55232</pub-id><pub-id pub-id-type="pmcid">PMC7358013</pub-id></mixed-citation></ref><ref id="cytoa24702-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="cytoa24702-cit-0016"><string-name name-style="western"><surname>Park</surname><given-names>LM</given-names></string-name>, <string-name name-style="western"><surname>Lannigan</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Jaimes</surname><given-names>MC</given-names></string-name>. <article-title>OMIP&#8208;069: forty&#8208;color full spectrum flow cytometry panel for deep immunophenotyping of major cell subsets in human peripheral blood</article-title>. <source>Cytometry A</source>. <year>2020</year>;<volume>97</volume>(<issue>10</issue>):<fpage>1044</fpage>&#8211;<lpage>51</lpage>.<pub-id pub-id-type="pmid">32830910</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cyto.a.24213</pub-id><pub-id pub-id-type="pmcid">PMC8132182</pub-id></mixed-citation></ref><ref id="cytoa24702-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="cytoa24702-cit-0017"><string-name name-style="western"><surname>Niewold</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Ashhurst</surname><given-names>TM</given-names></string-name>, <string-name name-style="western"><surname>Smith</surname><given-names>AL</given-names></string-name>, <string-name name-style="western"><surname>King</surname><given-names>NJC</given-names></string-name>. <article-title>Evaluating spectral cytometry for immune profiling in viral disease</article-title>. <source>Cytometry A</source>. <year>2020</year>;<volume>97</volume>(<issue>11</issue>):<fpage>1165</fpage>&#8211;<lpage>79</lpage>.<pub-id pub-id-type="pmid">32799382</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cyto.a.24211</pub-id></mixed-citation></ref><ref id="cytoa24702-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="cytoa24702-cit-0018"><string-name name-style="western"><surname>Klose</surname><given-names>CSN</given-names></string-name>, <string-name name-style="western"><surname>Flach</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>M&#246;hle</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Rogell</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Hoyler</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Ebert</surname><given-names>K</given-names></string-name>, et al. <article-title>Differentiation of type 1 ILCs from a common progenitor to all helper&#8208;like innate lymphoid cell lineages</article-title>. <source>Cell</source>. <year>2014</year>;<volume>157</volume>(<issue>2</issue>):<fpage>340</fpage>&#8211;<lpage>56</lpage>.<pub-id pub-id-type="pmid">24725403</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2014.03.030</pub-id></mixed-citation></ref><ref id="cytoa24702-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="cytoa24702-cit-0019"><string-name name-style="western"><surname>Ghaedi</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Shen</surname><given-names>ZY</given-names></string-name>, <string-name name-style="western"><surname>Orangi</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Martinez&#8208;Gonzalez</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Wei</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Lu</surname><given-names>X</given-names></string-name>, et al. <article-title>Single&#8208;cell analysis of ROR&#945; tracer mouse lung reveals ILC progenitors and effector ILC2 subsets</article-title>. <source>J Exp Med</source>. <year>2020</year>;<volume>217</volume>(<issue>3</issue>):<elocation-id>jem.20182293</elocation-id>.<pub-id pub-id-type="pmid">31816636</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1084/jem.20182293</pub-id><pub-id pub-id-type="pmcid">PMC7062532</pub-id></mixed-citation></ref><ref id="cytoa24702-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="cytoa24702-cit-0020"><string-name name-style="western"><surname>Zeis</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Lian</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Fan</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Herman</surname><given-names>JS</given-names></string-name>, <string-name name-style="western"><surname>Hernandez</surname><given-names>DC</given-names></string-name>, <string-name name-style="western"><surname>Gentek</surname><given-names>R</given-names></string-name>, et al. <article-title>In situ maturation and tissue adaptation of type 2 innate lymphoid cell progenitors</article-title>. <source>Immunity</source>. <year>2020</year>;<volume>53</volume>(<issue>4</issue>):<fpage>775</fpage>&#8211;<lpage>792.e9</lpage>.<pub-id pub-id-type="pmid">33002412</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.immuni.2020.09.002</pub-id><pub-id pub-id-type="pmcid">PMC7611573</pub-id></mixed-citation></ref><ref id="cytoa24702-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="cytoa24702-cit-0021"><string-name name-style="western"><surname>Lim</surname><given-names>AI</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Lopez&#8208;Lastra</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Stadhouders</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Paul</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Casrouge</surname><given-names>A</given-names></string-name>, et al. <article-title>Systemic human ILC precursors provide a substrate for tissue ILC differentiation</article-title>. <source>Cell</source>. <year>2017</year>;<volume>168</volume>(<issue>6</issue>):<fpage>1086</fpage>&#8211;<lpage>1100.e10</lpage>.<pub-id pub-id-type="pmid">28283063</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2017.02.021</pub-id></mixed-citation></ref><ref id="cytoa24702-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="cytoa24702-cit-0022"><string-name name-style="western"><surname>Constantinides</surname><given-names>MG</given-names></string-name>, <string-name name-style="western"><surname>McDonald</surname><given-names>BD</given-names></string-name>, <string-name name-style="western"><surname>Verhoef</surname><given-names>PA</given-names></string-name>, <string-name name-style="western"><surname>Bendelac</surname><given-names>A</given-names></string-name>. <article-title>A committed precursor to innate lymphoid cells</article-title>. <source>Nature</source>. <year>2014</year>;<volume>508</volume>(<issue>7496</issue>):<fpage>397</fpage>&#8211;<lpage>401</lpage>.<pub-id pub-id-type="pmid">24509713</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature13047</pub-id><pub-id pub-id-type="pmcid">PMC4003507</pub-id></mixed-citation></ref><ref id="cytoa24702-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="cytoa24702-cit-0023"><string-name name-style="western"><surname>Ishizuka</surname><given-names>IE</given-names></string-name>, <string-name name-style="western"><surname>Chea</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Gudjonson</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Constantinides</surname><given-names>MG</given-names></string-name>, <string-name name-style="western"><surname>Dinner</surname><given-names>AR</given-names></string-name>, <string-name name-style="western"><surname>Bendelac</surname><given-names>A</given-names></string-name>, et al. <article-title>Single&#8208;cell analysis defines the divergence between the innate lymphoid cell lineage and lymphoid tissue&#8208;inducer cell lineage</article-title>. <source>Nat Immunol</source>. <year>2016</year>;<volume>17</volume>(<issue>3</issue>):<fpage>269</fpage>&#8211;<lpage>76</lpage>.<pub-id pub-id-type="pmid">26779601</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ni.3344</pub-id><pub-id pub-id-type="pmcid">PMC4755916</pub-id></mixed-citation></ref><ref id="cytoa24702-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="cytoa24702-cit-0024"><string-name name-style="western"><surname>Martin</surname><given-names>CE</given-names></string-name>, <string-name name-style="western"><surname>Spasova</surname><given-names>DS</given-names></string-name>, <string-name name-style="western"><surname>Frimpong&#8208;Boateng</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Kim</surname><given-names>HO</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Kim</surname><given-names>KS</given-names></string-name>, et al. <article-title>Interleukin&#8208;7 availability is maintained by a hematopoietic cytokine sink comprising innate lymphoid cells and T cells</article-title>. <source>Immunity</source>. <year>2017</year>;<volume>47</volume>(<issue>1</issue>):<fpage>171</fpage>&#8211;<lpage>182.e4</lpage>.<pub-id pub-id-type="pmid">28723549</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.immuni.2017.07.005</pub-id></mixed-citation></ref><ref id="cytoa24702-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="cytoa24702-cit-0025"><string-name name-style="western"><surname>Weizman</surname><given-names>OE</given-names></string-name>, <string-name name-style="western"><surname>Adams</surname><given-names>NM</given-names></string-name>, <string-name name-style="western"><surname>Schuster</surname><given-names>IS</given-names></string-name>, <string-name name-style="western"><surname>Krishna</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Pritykin</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Lau</surname><given-names>C</given-names></string-name>, et al. <article-title>ILC1 confer early host protection at initial sites of viral infection</article-title>. <source>Cell</source>. <year>2017</year>;<volume>171</volume>(<issue>4</issue>):<fpage>795</fpage>&#8211;<lpage>808.e12</lpage>.<pub-id pub-id-type="pmid">29056343</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2017.09.052</pub-id><pub-id pub-id-type="pmcid">PMC5687850</pub-id></mixed-citation></ref><ref id="cytoa24702-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="cytoa24702-cit-0026"><string-name name-style="western"><surname>Hoyler</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Klose</surname><given-names>CS</given-names></string-name>, <string-name name-style="western"><surname>Souabni</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Turqueti&#8208;Neves</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Pfeifer</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Rawlins</surname><given-names>EL</given-names></string-name>, et al. <article-title>The transcription factor GATA&#8208;3 controls cell fate and maintenance of type 2 innate lymphoid cells</article-title>. <source>Immunity</source>. <year>2012</year>;<volume>37</volume>(<issue>4</issue>):<fpage>634</fpage>&#8211;<lpage>48</lpage>.<pub-id pub-id-type="pmid">23063333</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.immuni.2012.06.020</pub-id><pub-id pub-id-type="pmcid">PMC3662874</pub-id></mixed-citation></ref><ref id="cytoa24702-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="cytoa24702-cit-0027"><string-name name-style="western"><surname>Mj&#246;sberg</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Bernink</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Golebski</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Karrich</surname><given-names>JJ</given-names></string-name>, <string-name name-style="western"><surname>Peters</surname><given-names>CP</given-names></string-name>, <string-name name-style="western"><surname>Blom</surname><given-names>B</given-names></string-name>, et al. <article-title>The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells</article-title>. <source>Immunity</source>. <year>2012</year>;<volume>37</volume>(<issue>4</issue>):<fpage>649</fpage>&#8211;<lpage>59</lpage>.<pub-id pub-id-type="pmid">23063330</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.immuni.2012.08.015</pub-id></mixed-citation></ref><ref id="cytoa24702-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="cytoa24702-cit-0028"><string-name name-style="western"><surname>Moro</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Yamada</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Tanabe</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Takeuchi</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Ikawa</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Kawamoto</surname><given-names>H</given-names></string-name>, et al. <article-title>Innate production of TH2 cytokines by adipose tissue&#8208;associated c&#8208;Kit+Sca&#8208;1+ lymphoid cells</article-title>. <source>Nature</source>. <year>2010</year>;<volume>463</volume>(<issue>7280</issue>):<fpage>540</fpage>&#8211;<lpage>4</lpage>.<pub-id pub-id-type="pmid">20023630</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature08636</pub-id></mixed-citation></ref><ref id="cytoa24702-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="cytoa24702-cit-0029"><string-name name-style="western"><surname>Neill</surname><given-names>DR</given-names></string-name>, <string-name name-style="western"><surname>Wong</surname><given-names>SH</given-names></string-name>, <string-name name-style="western"><surname>Bellosi</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Flynn</surname><given-names>RJ</given-names></string-name>, <string-name name-style="western"><surname>Daly</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Langford</surname><given-names>TKA</given-names></string-name>, et al. <article-title>Nuocytes represent a new innate effector leukocyte that mediates type&#8208;2 immunity</article-title>. <source>Nature</source>. <year>2010</year>;<volume>464</volume>(<issue>7293</issue>):<fpage>1367</fpage>&#8211;<lpage>70</lpage>.<pub-id pub-id-type="pmid">20200518</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature08900</pub-id><pub-id pub-id-type="pmcid">PMC2862165</pub-id></mixed-citation></ref><ref id="cytoa24702-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="cytoa24702-cit-0030"><string-name name-style="western"><surname>Patel</surname><given-names>DF</given-names></string-name>, <string-name name-style="western"><surname>Peir&#243;</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Bruno</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Vuononvirta</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Akthar</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Puttur</surname><given-names>F</given-names></string-name>, et al. <article-title>Neutrophils restrain allergic airway inflammation by limiting ILC2 function and monocyte&#8211;dendritic cell antigen presentation</article-title>. <source>Sci Immunol</source>. <year>2019</year>;<volume>4</volume>(<issue>41</issue>):<fpage>eaax7006</fpage>.<pub-id pub-id-type="pmid">31704734</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/sciimmunol.aax7006</pub-id><pub-id pub-id-type="pmcid">PMC7613621</pub-id></mixed-citation></ref><ref id="cytoa24702-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="cytoa24702-cit-0031"><string-name name-style="western"><surname>Halim</surname><given-names>TYF</given-names></string-name>, <string-name name-style="western"><surname>Krauss</surname><given-names>RH</given-names></string-name>, <string-name name-style="western"><surname>Sun</surname><given-names>AC</given-names></string-name>, <string-name name-style="western"><surname>Takei</surname><given-names>F</given-names></string-name>. <article-title>Lung natural helper cells are a critical source of Th2 cell&#8208;type cytokines in protease allergen&#8208;induced airway inflammation</article-title>. <source>Immunity</source>. <year>2012</year>;<volume>36</volume>(<issue>3</issue>):<fpage>451</fpage>&#8211;<lpage>63</lpage>.<pub-id pub-id-type="pmid">22425247</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.immuni.2011.12.020</pub-id></mixed-citation></ref><ref id="cytoa24702-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="cytoa24702-cit-0032"><string-name name-style="western"><surname>Bartemes</surname><given-names>KR</given-names></string-name>, <string-name name-style="western"><surname>Kephart</surname><given-names>GM</given-names></string-name>, <string-name name-style="western"><surname>Fox</surname><given-names>SJ</given-names></string-name>, <string-name name-style="western"><surname>Kita</surname><given-names>H</given-names></string-name>. <article-title>Enhanced innate type 2 immune response in peripheral blood from patients with asthma</article-title>. <source>J Allergy Clin Immunol</source>. <year>2014</year>;<volume>134</volume>(<issue>3</issue>):<fpage>671</fpage>&#8211;<lpage>678.e4</lpage>.<pub-id pub-id-type="pmid">25171868</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jaci.2014.06.024</pub-id><pub-id pub-id-type="pmcid">PMC4149890</pub-id></mixed-citation></ref><ref id="cytoa24702-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="cytoa24702-cit-0033"><string-name name-style="western"><surname>Puttur</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Denney</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Gregory</surname><given-names>LG</given-names></string-name>, <string-name name-style="western"><surname>Vuononvirta</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Oliver</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Entwistle</surname><given-names>LJ</given-names></string-name>, et al. <article-title>Pulmonary environmental cues drive group 2 innate lymphoid cell dynamics in mice and humans</article-title>. <source>Sci Immunol</source>. <year>2019</year>;<volume>4</volume>(<issue>36</issue>):<fpage>eaav7638</fpage>.<pub-id pub-id-type="pmid">31175176</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/sciimmunol.aav7638</pub-id><pub-id pub-id-type="pmcid">PMC6744282</pub-id></mixed-citation></ref><ref id="cytoa24702-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="cytoa24702-cit-0034"><string-name name-style="western"><surname>Huang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Guo</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Qiu</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Hu&#8208;Li</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Siebenlist</surname><given-names>U</given-names></string-name>, et al. <article-title>IL&#8208;25&#8208;responsive, lineage&#8208;negative KLRG1(hi) cells are multipotential &#8216;inflammatory&#8217; type 2 innate lymphoid cells</article-title>. <source>Nat Immunol</source>. <year>2015</year>;<volume>16</volume>(<issue>2</issue>):<fpage>161</fpage>&#8211;<lpage>9</lpage>.<pub-id pub-id-type="pmid">25531830</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ni.3078</pub-id><pub-id pub-id-type="pmcid">PMC4297567</pub-id></mixed-citation></ref><ref id="cytoa24702-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="cytoa24702-cit-0035"><string-name name-style="western"><surname>Li</surname><given-names>BWS</given-names></string-name>, <string-name name-style="western"><surname>Stadhouders</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>de Bruijn</surname><given-names>MJW</given-names></string-name>, <string-name name-style="western"><surname>Lukkes</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Beerens</surname><given-names>DMJM</given-names></string-name>, <string-name name-style="western"><surname>Brem</surname><given-names>MD</given-names></string-name>, et al. <article-title>Group 2 innate lymphoid cells exhibit a dynamic phenotype in allergic airway inflammation</article-title>. <source>Front Immunol</source>. <year>2017</year>;<volume>8</volume>:<fpage>1684</fpage>.<pub-id pub-id-type="pmid">29250067</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2017.01684</pub-id><pub-id pub-id-type="pmcid">PMC5716969</pub-id></mixed-citation></ref><ref id="cytoa24702-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="cytoa24702-cit-0036"><string-name name-style="western"><surname>Ohne</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Silver</surname><given-names>JS</given-names></string-name>, <string-name name-style="western"><surname>Thompson&#8208;Snipes</surname><given-names>LA</given-names></string-name>, <string-name name-style="western"><surname>Collet</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Blanck</surname><given-names>JP</given-names></string-name>, <string-name name-style="western"><surname>Cantarel</surname><given-names>BL</given-names></string-name>, et al. <article-title>IL&#8208;1 is a critical regulator of group 2 innate lymphoid cell function and plasticity</article-title>. <source>Nat Immunol</source>. <year>2016</year>;<volume>17</volume>(<issue>6</issue>):<fpage>646</fpage>&#8211;<lpage>55</lpage>.<pub-id pub-id-type="pmid">27111142</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ni.3447</pub-id></mixed-citation></ref><ref id="cytoa24702-bib-0037"><label>37</label><mixed-citation publication-type="journal" id="cytoa24702-cit-0037"><string-name name-style="western"><surname>Ohne</surname><given-names>Y</given-names></string-name>. <article-title>OMIP&#8208;066: identification of novel subpopulations of human group 2 innate lymphoid cells in peripheral blood</article-title>. <source>Cytometry A</source>. <year>2020</year>;<volume>97</volume>(<issue>10</issue>):<fpage>1028</fpage>&#8211;<lpage>31</lpage>.<pub-id pub-id-type="pmid">32583618</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cyto.a.24046</pub-id></mixed-citation></ref><ref id="cytoa24702-bib-0038"><label>38</label><mixed-citation publication-type="journal" id="cytoa24702-cit-0038"><string-name name-style="western"><surname>Gladiator</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Wangler</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Trautwein&#8208;Weidner</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>LeibundGut&#8208;Landmann</surname><given-names>S</given-names></string-name>. <article-title>Cutting edge: IL&#8208;17&#8208;secreting innate lymphoid cells are essential for host defense against fungal infection</article-title>. <source>J Immunol</source>. <year>2013</year>;<volume>190</volume>(<issue>2</issue>):<fpage>521</fpage>&#8211;<lpage>5</lpage>.<pub-id pub-id-type="pmid">23255360</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4049/jimmunol.1202924</pub-id></mixed-citation></ref><ref id="cytoa24702-bib-0039"><label>39</label><mixed-citation publication-type="journal" id="cytoa24702-cit-0039"><string-name name-style="western"><surname>Buonocore</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Ahern</surname><given-names>PP</given-names></string-name>, <string-name name-style="western"><surname>Uhlig</surname><given-names>HH</given-names></string-name>, <string-name name-style="western"><surname>Ivanov</surname><given-names>II</given-names></string-name>, <string-name name-style="western"><surname>Littman</surname><given-names>DR</given-names></string-name>, <string-name name-style="western"><surname>Maloy</surname><given-names>KJ</given-names></string-name>, et al. <article-title>Innate lymphoid cells drive interleukin&#8208;23&#8208;dependent innate intestinal pathology</article-title>. <source>Nature</source>. <year>2010</year>;<volume>464</volume>(<issue>7293</issue>):<fpage>1371</fpage>&#8211;<lpage>5</lpage>.<pub-id pub-id-type="pmid">20393462</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature08949</pub-id><pub-id pub-id-type="pmcid">PMC3796764</pub-id></mixed-citation></ref><ref id="cytoa24702-bib-0040"><label>40</label><mixed-citation publication-type="journal" id="cytoa24702-cit-0040"><string-name name-style="western"><surname>Van Maele</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Carnoy</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Cayet</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Ivanov</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Porte</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Deruy</surname><given-names>E</given-names></string-name>, et al. <article-title>Activation of type 3 innate lymphoid cells and interleukin 22 secretion in the lungs during <italic toggle="yes">Streptococcus pneumoniae</italic> infection</article-title>. <source>J Infect Dis</source>. <year>2014</year>;<volume>210</volume>(<issue>3</issue>):<fpage>493</fpage>&#8211;<lpage>503</lpage>.<pub-id pub-id-type="pmid">24577508</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/infdis/jiu106</pub-id></mixed-citation></ref><ref id="cytoa24702-bib-0041"><label>41</label><mixed-citation publication-type="journal" id="cytoa24702-cit-0041"><string-name name-style="western"><surname>Dutton</surname><given-names>EE</given-names></string-name>, <string-name name-style="western"><surname>Withers</surname><given-names>DR</given-names></string-name>. <article-title>Identification of murine innate lymphoid cell subsets in barrier tissues and their draining lymph nodes using flow cytometry</article-title>. <source>Methods Mol Biol</source>. <year>2020</year>;<volume>2121</volume>:<fpage>23</fpage>.<pub-id pub-id-type="pmid">32147783</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/978-1-0716-0338-3_3</pub-id></mixed-citation></ref><ref id="cytoa24702-bib-0042"><label>42</label><mixed-citation publication-type="journal" id="cytoa24702-cit-0042"><string-name name-style="western"><surname>Sanos</surname><given-names>SL</given-names></string-name>, <string-name name-style="western"><surname>Bui</surname><given-names>VL</given-names></string-name>, <string-name name-style="western"><surname>Mortha</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Oberle</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Heners</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Johner</surname><given-names>C</given-names></string-name>, et al. <article-title>RORgammat and commensal microflora are required for the differentiation of mucosal interleukin 22&#8208;producing NKp46+ cells</article-title>. <source>Nat Immunol</source>. <year>2009</year>;<volume>10</volume>(<issue>1</issue>):<fpage>83</fpage>&#8211;<lpage>91</lpage>.<pub-id pub-id-type="pmid">19029903</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ni.1684</pub-id><pub-id pub-id-type="pmcid">PMC4217274</pub-id></mixed-citation></ref><ref id="cytoa24702-bib-0043"><label>43</label><mixed-citation publication-type="journal" id="cytoa24702-cit-0043"><string-name name-style="western"><surname>Satoh&#8208;Takayama</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Vosshenrich</surname><given-names>CAJ</given-names></string-name>, <string-name name-style="western"><surname>Lesjean&#8208;Pottier</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Sawa</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Lochner</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Rattis</surname><given-names>F</given-names></string-name>, et al. <article-title>Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense</article-title>. <source>Immunity</source>. <year>2008</year>;<volume>29</volume>(<issue>6</issue>):<fpage>958</fpage>&#8211;<lpage>70</lpage>.<pub-id pub-id-type="pmid">19084435</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.immuni.2008.11.001</pub-id></mixed-citation></ref><ref id="cytoa24702-bib-0044"><label>44</label><mixed-citation publication-type="journal" id="cytoa24702-cit-0044"><string-name name-style="western"><surname>Luci</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Reynders</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Ivanov</surname><given-names>II</given-names></string-name>, <string-name name-style="western"><surname>Cognet</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Chiche</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Chasson</surname><given-names>L</given-names></string-name>, et al. <article-title>Influence of the transcription factor RORgammat on the development of NKp46+ cell populations in gut and skin</article-title>. <source>Nat Immunol</source>. <year>2009</year>;<volume>10</volume>(<issue>1</issue>):<fpage>75</fpage>&#8211;<lpage>82</lpage>.<pub-id pub-id-type="pmid">19029904</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ni.1681</pub-id></mixed-citation></ref><ref id="cytoa24702-bib-0045"><label>45</label><mixed-citation publication-type="journal" id="cytoa24702-cit-0045"><string-name name-style="western"><surname>Valle&#8208;Noguera</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>G&#243;mez&#8208;S&#225;nchez</surname><given-names>MJ</given-names></string-name>, <string-name name-style="western"><surname>Girard&#8208;Madoux</surname><given-names>MJH</given-names></string-name>, <string-name name-style="western"><surname>Cruz&#8208;Adalia</surname><given-names>A</given-names></string-name>. <article-title>Optimized protocol for characterization of mouse gut innate lymphoid cells</article-title>. <source>Front Immunol</source>. <year>2020</year>;<volume>11</volume>:<fpage>563414</fpage>.<pub-id pub-id-type="pmid">33329525</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2020.563414</pub-id><pub-id pub-id-type="pmcid">PMC7735015</pub-id></mixed-citation></ref><ref id="cytoa24702-bib-0046"><label>46</label><mixed-citation publication-type="journal" id="cytoa24702-cit-0046"><string-name name-style="western"><surname>Klose</surname><given-names>CSN</given-names></string-name>, <string-name name-style="western"><surname>Kiss</surname><given-names>EA</given-names></string-name>, <string-name name-style="western"><surname>Schwierzeck</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Ebert</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Hoyler</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>d'Hargues</surname><given-names>Y</given-names></string-name>, et al. <article-title>A T&#8208;bet gradient controls the fate and function of CCR6&#8211;ROR&#947;t+ innate lymphoid cells</article-title>. <source>Nature</source>. <year>2013</year>;<volume>494</volume>(<issue>7436</issue>):<fpage>261</fpage>&#8211;<lpage>5</lpage>.<pub-id pub-id-type="pmid">23334414</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature11813</pub-id></mixed-citation></ref><ref id="cytoa24702-bib-0047"><label>47</label><mixed-citation publication-type="journal" id="cytoa24702-cit-0047"><string-name name-style="western"><surname>Rankin</surname><given-names>LC</given-names></string-name>, <string-name name-style="western"><surname>Groom</surname><given-names>JR</given-names></string-name>, <string-name name-style="western"><surname>Chopin</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Herold</surname><given-names>MJ</given-names></string-name>, <string-name name-style="western"><surname>Walker</surname><given-names>JA</given-names></string-name>, <string-name name-style="western"><surname>Mielke</surname><given-names>LA</given-names></string-name>, et al. <article-title>The transcription factor T&#8208;bet is essential for the development of NKp46+ innate lymphocytes via the notch pathway</article-title>. <source>Nat Immunol</source>. <year>2013</year>;<volume>14</volume>(<issue>4</issue>):<fpage>389</fpage>&#8211;<lpage>95</lpage>.<pub-id pub-id-type="pmid">23455676</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ni.2545</pub-id><pub-id pub-id-type="pmcid">PMC4076532</pub-id></mixed-citation></ref><ref id="cytoa24702-bib-0048"><label>48</label><mixed-citation publication-type="journal" id="cytoa24702-cit-0048"><string-name name-style="western"><surname>Sahir</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Mateo</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Steinhoff</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Siveen</surname><given-names>KS</given-names></string-name>. <article-title>Development of a 43 color panel for the characterization of conventional and unconventional T&#8208;cell subsets, B cells, NK cells, monocytes, dendritic cells, and innate lymphoid cells using spectral flow cytometry</article-title>. <source>Cytometry A</source>. <year>2020</year>;<fpage>1</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1002/cyto.a.24288</pub-id><pub-id pub-id-type="pmcid">PMC11497249</pub-id><pub-id pub-id-type="pmid">33336868</pub-id><related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="expression-of-concern" ext-link-type="pmc" xlink:href="PMC11524668"/></mixed-citation></ref><ref id="cytoa24702-bib-0049"><label>49</label><mixed-citation publication-type="journal" id="cytoa24702-cit-0049"><string-name name-style="western"><surname>Ricardo&#8208;Gonzalez</surname><given-names>RR</given-names></string-name>, <string-name name-style="western"><surname>van Dyken</surname><given-names>SJ</given-names></string-name>, <string-name name-style="western"><surname>Schneider</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Nussbaum</surname><given-names>JC</given-names></string-name>, <string-name name-style="western"><surname>Liang</surname><given-names>HE</given-names></string-name>, et al. <article-title>Tissue signals imprint ILC2 identity with anticipatory function</article-title>. <source>Nat Immunol</source>. <year>2018</year>;<volume>19</volume>(<issue>10</issue>):<fpage>1093</fpage>&#8211;<lpage>9</lpage>.<pub-id pub-id-type="pmid">30201992</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41590-018-0201-4</pub-id><pub-id pub-id-type="pmcid">PMC6202223</pub-id></mixed-citation></ref><ref id="cytoa24702-bib-0050"><label>50</label><mixed-citation publication-type="journal" id="cytoa24702-cit-0050"><string-name name-style="western"><surname>Monticelli</surname><given-names>LA</given-names></string-name>, <string-name name-style="western"><surname>Sonnenberg</surname><given-names>GF</given-names></string-name>, <string-name name-style="western"><surname>Abt</surname><given-names>MC</given-names></string-name>, <string-name name-style="western"><surname>Alenghat</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Ziegler</surname><given-names>CG</given-names></string-name>, <string-name name-style="western"><surname>Doering</surname><given-names>TA</given-names></string-name>, et al. <article-title>Innate lymphoid cells promote lung&#8208;tissue homeostasis after infection with influenza virus</article-title>. <source>Nat Immunol</source>. <year>2011</year>;<volume>12</volume>(<issue>11</issue>):<fpage>1045</fpage>&#8211;<lpage>54</lpage>.<pub-id pub-id-type="pmid">21946417</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1031/ni.2131</pub-id><pub-id pub-id-type="pmcid">PMC3320042</pub-id></mixed-citation></ref><ref id="cytoa24702-bib-0051"><label>51</label><mixed-citation publication-type="journal" id="cytoa24702-cit-0051"><string-name name-style="western"><surname>Melo&#8208;Gonzalez</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Hepworth</surname><given-names>MR</given-names></string-name>. <article-title>Functional and phenotypic heterogeneity of group 3 innate lymphoid cells</article-title>. <source>Immunology</source>. <year>2017</year>;<volume>150</volume>(<issue>3</issue>):<fpage>265</fpage>&#8211;<lpage>75</lpage>.<pub-id pub-id-type="pmid">27935637</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/imm.12697</pub-id><pub-id pub-id-type="pmcid">PMC5290240</pub-id></mixed-citation></ref><ref id="cytoa24702-bib-0052"><label>52</label><mixed-citation publication-type="journal" id="cytoa24702-cit-0052"><string-name name-style="western"><surname>Kim</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Iizuka</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Kang</surname><given-names>HSP</given-names></string-name>, <string-name name-style="western"><surname>Dokun</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>French</surname><given-names>AR</given-names></string-name>, <string-name name-style="western"><surname>Greco</surname><given-names>S</given-names></string-name>, et al. <article-title>In vivo developmental stages in murine natural killer cell maturation</article-title>. <source>Nat Immunol</source>. <year>2002</year>;<volume>3</volume>(<issue>6</issue>):<fpage>523</fpage>&#8211;<lpage>8</lpage>.<pub-id pub-id-type="pmid">12006976</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ni796</pub-id></mixed-citation></ref><ref id="cytoa24702-bib-0053"><label>53</label><mixed-citation publication-type="journal" id="cytoa24702-cit-0053"><string-name name-style="western"><surname>Sojka</surname><given-names>DK</given-names></string-name>, <string-name name-style="western"><surname>Plougastel&#8208;Douglas</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Yang</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Pak&#8208;Wittel</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Artyomov</surname><given-names>MN</given-names></string-name>, <string-name name-style="western"><surname>Ivanova</surname><given-names>Y</given-names></string-name>, et al. <article-title>Tissue&#8208;resident natural killer (NK) cells are cell lineages distinct from thymic and conventional splenic NK cells</article-title>. <source>Elife</source>. <year>2014</year>;<volume>3</volume>:<elocation-id>e01659</elocation-id>.<pub-id pub-id-type="pmid">24714492</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7554/eLife.01659</pub-id><pub-id pub-id-type="pmcid">PMC3975579</pub-id></mixed-citation></ref><ref id="cytoa24702-bib-0054"><label>54</label><mixed-citation publication-type="journal" id="cytoa24702-cit-0054"><string-name name-style="western"><surname>Huntington</surname><given-names>ND</given-names></string-name>, <string-name name-style="western"><surname>Tabarias</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Fairfax</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Brady</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Hayakawa</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Degli&#8208;Esposti</surname><given-names>MA</given-names></string-name>, et al. <article-title>NK cell maturation and peripheral homeostasis is associated with KLRG1 up&#8208;regulation</article-title>. <source>J Immunol</source>. <year>2007</year>;<volume>178</volume>(<issue>8</issue>):<fpage>4764</fpage>&#8211;<lpage>70</lpage>.<pub-id pub-id-type="pmid">17404256</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4049/jimmunol.178.8.4764</pub-id></mixed-citation></ref><ref id="cytoa24702-bib-0055"><label>55</label><mixed-citation publication-type="journal" id="cytoa24702-cit-0055"><string-name name-style="western"><surname>Sanos</surname><given-names>SL</given-names></string-name> et al. <article-title>Isolation of NK cells and NK&#8208;like cells from the intestinal lamina propria</article-title>. <source>Methods Mol Biol</source>. <year>2010</year>;<volume>612</volume>:<fpage>505</fpage>.<pub-id pub-id-type="pmid">20033661</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/978-1-60761-362-6_32</pub-id></mixed-citation></ref><ref id="cytoa24702-bib-0056"><label>56</label><mixed-citation publication-type="journal" id="cytoa24702-cit-0056"><string-name name-style="western"><surname>Culley</surname><given-names>FJ</given-names></string-name>. <article-title>Natural killer cells in infection and inflammation of the lung</article-title>. <source>Immunology</source>. <year>2009</year>;<volume>128</volume>(<issue>2</issue>):<fpage>151</fpage>&#8211;<lpage>63</lpage>.<pub-id pub-id-type="pmid">19740372</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1365-2567.2009.03167.x</pub-id><pub-id pub-id-type="pmcid">PMC2767305</pub-id></mixed-citation></ref><ref id="cytoa24702-bib-0057"><label>57</label><mixed-citation publication-type="journal" id="cytoa24702-cit-0057"><string-name name-style="western"><surname>Kumar</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Thakar</surname><given-names>MS</given-names></string-name>, <string-name name-style="western"><surname>Ouyang</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Malarkannan</surname><given-names>S</given-names></string-name>. <article-title>IL&#8208;22 from conventional NK cells is epithelial regenerative and inflammation protective during influenza infection</article-title>. <source>Mucosal Immunol</source>. <year>2013</year>;<volume>6</volume>(<issue>1</issue>):<fpage>69</fpage>&#8211;<lpage>82</lpage>.<pub-id pub-id-type="pmid">22739232</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/mi.2012.49</pub-id><pub-id pub-id-type="pmcid">PMC3835350</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>